JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis.

Walz, Lucas; Cohen, Avi J; Rebaza, Andre P; Vanchieri, James; Slade, Martin D; Dela Cruz, Charles S; Sharma, Lokesh

Walz, Lucas; Cohen, Avi J; Rebaza, Andre P; Vanchieri, James; Slade, Martin D; Dela Cruz, Charles S; Sharma, Lokesh.

Afiliação

Walz L; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06520, USA.
Cohen AJ; Section of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, S440, 300 Cedar Street, New Haven, CT, 06520, USA.
Rebaza AP; Section of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, S440, 300 Cedar Street, New Haven, CT, 06520, USA.
Vanchieri J; Section of Pediatric Pulmonary, Allergy, Immunology and Sleep Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, CT, 06520, USA.
Slade MD; Section of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, S440, 300 Cedar Street, New Haven, CT, 06520, USA.
Dela Cruz CS; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 06520, USA.
Sharma L; Section of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, S440, 300 Cedar Street, New Haven, CT, 06520, USA. charles.delacruz@yale.edu.

BMC Infect Dis ; 21(1): 47, 2021 Jan 11.

Article em En | MEDLINE | ID: mdl-33430799

Assuntos

Tratamento Farmacológico da COVID-19; COVID-19/imunologia; Interferon Tipo I/uso terapêutico; Inibidores de Janus Quinases/uso terapêutico; Humanos; Interferon Tipo I/imunologia; SARS-CoV-2/imunologia; SARS-CoV-2/patogenicidade; Resultado do Tratamento

Palavras-chave

Infection control; Respiratory infection; Viral infection

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Inibidores de Janus Quinases / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google